Completed NA INTERVENTIONAL 2-arm NCT02164695

Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction (CAPRI)

Cardioprotective Effects of Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Sponsor: Yonsei University

Conditions ST-segment Elevation Myocardial Infarction

Interventions PPCI only PPCI plus RIPC

Updated 8 times since 2017 Last updated: Nov 23, 2021 Started: Jan 31, 2015 Primary completion: Jul 31, 2017 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates ST-segment Elevation Myocardial Infarction and is currently completed. Yonsei University leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Mar 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed · Phase: PHASE3 → NA
Jan 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE3

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yonsei University

Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wŏnju, South Korea